News
TipRanks on MSN20h
Travere Therapeutics price target raised to $34 from $32 at CitiCiti raised the firm’s price target on Travere Therapeutics (TVTX) to $34 from $32 and keeps a Buy rating on the shares. The firm sees meaningful ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results